R. Preston Mason, Ph.D.
Professor and senior research staff scientist at Brigham & Women's Hospital, Harvard Medical School.
Focuses on vascular biology, endothelial function and LDL-oxidation. Most recent work specifically
addresses the issue of what may explain the increasing rate of atherosclerotic CAD events in patients
taking certain Cox-2 inhibitors.
Gilbert M. Rishton, Ph.D.
Founder and Director of the non-profit, Channel Islands Alzheimer’s Institute. Led medicinal
chemistry efforts in pharma for over fifteen years, most recently at Amgen.
